Secondary Logo

Journal Logo

March 2019 - Volume 42 - Issue 3
pp: 231-329



Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center

Zhang, Kevin J.; Dyson, Greg; Gatz, Joshua L.; More

American Journal of Clinical Oncology. 42(3):243-246, March 2019.

Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer

Kharofa, Jordan; Mierzwa, Michelle; Olowokure, Olugbenga; More

American Journal of Clinical Oncology. 42(3):247-252, March 2019.


Central Nervous System

Supportive Care


A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer

Rice, Stephanie R.; Olexa, Gloribel; Hussain, Arif; More

American Journal of Clinical Oncology. 42(3):285-291, March 2019.